저널: Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Website: 설명: 1210-7816Praha : Ceská lékarská spolecnost J. E. Purkyne,. SARS-CoV-2(3) COVID-19(3) triazavirin(3) ACE-2(2) structural proteins(2) 3-chymotrypsin-like protease(2) Drug repurposing(2) practical experiences(1) clinical trials(1) Riamilovir(1) The efficacy of triazavirin (riamilovir)-based treatment for coronavirus disease 2019 (COVID-19) in clinical trials and preliminary practical experiencesReview Published on 2022-01-012023-07-11 Journal: Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a [Category] COVID19(2023년), [키워드] clinical trials COVID-19 practical experiences Riamilovir SARS-CoV-2 triazavirin [Article Type] Review Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Article Published on 2021-01-012023-06-23 Journal: Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a [Category] SARS, 신종인플루엔자, [키워드] 3-chymotrypsin-like protease ACE-2 COVID-19 Drug repurposing SARS-CoV-2 structural proteins triazavirin
The efficacy of triazavirin (riamilovir)-based treatment for coronavirus disease 2019 (COVID-19) in clinical trials and preliminary practical experiencesReview Published on 2022-01-012023-07-11 Journal: Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a [Category] COVID19(2023년), [키워드] clinical trials COVID-19 practical experiences Riamilovir SARS-CoV-2 triazavirin [Article Type] Review
Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Article Published on 2021-01-012023-06-23 Journal: Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a [Category] SARS, 신종인플루엔자, [키워드] 3-chymotrypsin-like protease ACE-2 COVID-19 Drug repurposing SARS-CoV-2 structural proteins triazavirin